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Abstract
Background and Objective—Accurately recording vaccine lot number, expiration date, and 
product identifiers, in patient records is an important step in improving supply chain management 
and patient safety in the event of a recall. These data are being encoded on two-dimensional (2D) 
barcodes on most vaccine vials and syringes. Using electronic vaccine administration records, we 
evaluated the accuracy of lot number and expiration date entered using 2D barcode scanning 
compared to traditional manual or drop-down list entry methods.
Methods—We analyzed 128,573 electronic records of vaccines administered at 32 facilities. We 
compared the accuracy of records entered using 2D barcode scanning with those entered using 
traditional methods using chi-square tests and multilevel logistic regression.
Results—When 2D barcodes were scanned, lot number data accuracy was 1.8 percentage points 
higher (94.3% to 96.1%, P < .001) and expiration date data accuracy was 11 percentage points 
higher (84.8% to 95.8%, P < .001) compared with traditional methods. In multivariate analysis, lot 
number was more likely to be accurate (aOR = 1.75; 99% CI, 1.57–1.96) as was expiration date 
(aOR = 2.39; 99% CI, 2.12–2.68). When controlling for scanning and other factors, manufacturer, 
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month vaccine was administered, and vaccine type were associated with variation in accuracy for 
both lot number and expiration date.
Conclusion—Two-dimensional barcode scanning shows promise for improving data accuracy of 
vaccine lot number and expiration date records. Adapting systems to further integrate with 2D 
barcoding could help increase adoption of 2D barcode scanning technology.
Keywords
vaccines; immunization; automatic data processing; 2D barcode technology; electronic health 
record; technology adoption
Background and Objectives
The National Childhood Vaccine Injury Act (NCVIA), passed in 1986, requires that 
healthcare providers record certain data, including lot number, for all vaccines administered.
[1] The American Academy of Pediatrics and the Centers for Disease Control and 
Prevention (CDC) recommend also recording additional data elements, including expiration 
date.[2,3] Despite these requirements and recommendations, in 2011 only 60% of 
Immunization Information System (IIS) vaccination records for children younger than six 
years of age included the vaccine lot number.[4] Evidence suggests that vaccine data 
elements recorded in EMRs are not always recorded accurately.[5–10] Missing and 
inaccurate data may be due in part to the fact that providers read and interpret printed lot 
number and expiration date on vaccine vials and then enter data manually into the electronic 
medical record (EMR).
Consistent and accurate documentation of vaccine lot number and expiration date in patient 
records is a first step in determining whether recalled or expired vaccines have been 
administered, identifying lots associated with adverse events for possible recall, and 
facilitating efficient and effective vaccine inventory management. In 2004, the U.S. Food 
and Drug Administration (FDA) passed a labeling rule requiring the placement of a 
machine-readable linear barcode containing the National Drug Code (NDC) on certain 
human drug and biological products, including vaccines, to reduce medication errors.[11] 
The NDC can be used to identify manufacturer (or labeler), vaccine product, and packaging; 
however, it cannot be used to determine lot number or expiration date.[12] Due to the 
importance of these additional data elements, the FDA published guidance in 2011 
permitting vaccine manufacturers to request a waiver and replace linear barcodes with 
“alternative technology such as two dimensional symbology” capable of capturing additional 
data elements (Figure 1).[13] Two-dimensional vaccine barcodes encode NDC, lot number 
and expiration date, and as of July 2016, there were over 90 2D barcoded vaccines.[14]
Theoretically, scanning 2D barcoded vaccines should increase the accuracy of vaccination 
records in EMRs, compared with manual data entry. However, the effect of 2D barcode 
scanning on vaccine data accuracy has not been widely studied.[10,15–16] In this 
evaluation, we assess the accuracy of lot number and expiration date in records entered via 
2D barcode scanning compared with traditional data entry methods (e.g., drop down menu 
with jump capability, manual typing, or a combination of the two).
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To recruit facilities, we contacted facilities that had expressed interest but were not enrolled 
in a previous CDC 2D vaccine barcode evaluation.[17] Additionally, we conducted targeted 
recruitment of other types of facilities (e.g., community vaccinators and pharmacies). We 
included facilities that: (1) were likely to use vaccines with 2D barcodes scheduled for 
distribution during the project period; (2) volunteered to scan 2D barcoded vaccines 
administered into their EMRs; (3) agreed to report de-identified EMR vaccine administration 
data for this evaluation; (4) used an EMR system to capture vaccine administration data that 
could be configured to input data using a 2D barcode scanner; and (5) agreed to use 
technology that allowed us to determine if the lot number and expiration date for a given 
vaccine administration was entered into the system with a 2D barcode scanner.
For each participating facility, we provided, installed, and configured corded, handheld 
image scanners with USB interface (i.e., 2D barcode scanners) to scan 2D barcoded vaccines 
to enter lot number and expiration date into EMRs. We conducted in-person staff training on 
use of scanners. Staff entered lot number and expiration date directly into EMRs using either 
2D barcode scanning or traditional methods, depending on presence or absence of a 2D 
barcode; staff were encouraged, not required, to scan a 2D barcode if one was available. This 
evaluation was deemed to be public health practice and did not require IRB review.
Data Sources
We collected EMR data for all linear and 2D barcoded vaccines administered between July 
1, 2014 and January 31, 2015. To determine whether scanning took place, we used a flag on 
records (native scan logs) or supporting text files (installed scan logs)1. Some facilities 
employed an EMR system capable of tracking which vaccine records were entered into the 
system via a 2D barcode scanner (native scan log). Other facilities allowed us to install 
software to record data from the scanner into a separate text file to indicate whether a 2D 
barcode was scanned (installed scan log); to be considered scanned, the text file had to 
match an EMR record on lot number, time recorded, and date recorded. EMR vaccine 
administration records that did not match the text file across all three data points were 
considered entered via “traditional methods.”
We determined whether lot number and expiration date entries were accurate by comparing 
data in the EMRs with a reference file containing 31,441 unique lot numbers. Lot numbers 
were compared to the reference file and considered accurate if a valid match was identified. 
The reference file was created from five sources: files from three manufacturers of 2D 
barcoded vaccines; records from the Vaccine for Children’s (VFC) program; facility 
shipping manifests; facility inventory records; and Vaccine Adverse Events Reporting 
System (VAERS) data.[18] Manufacturer files and VFC data were supplemented by the 
other sources only if certain criteria were met (e.g., previously unidentified lot numbers had 
appeared at least three times in VAERS). Four of the five reference file sources included 
1Where facilities had existing EMRs capable of identifying which records were entered using a 2D scanner, we referred to those 
facilities as having native scan logs. At installed scan log facilities, the team had to install a text document to record vaccine 
information populated through 2D scanning and then match the text file records to the EMR data.
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information from one year before start of this evaluation (July 2013) through January 2015; 
VFC records contained vaccines shipped from May 2014 to January 2015.
All facilities had EMR systems that automatically populated vaccine lot number by scanning 
the 2D barcode; however, not all EMRs could capture expiration date from the scan. When 
expiration date was populated from an inventory system or a prepopulated table, records 
were excluded from the analysis of expiration date. Expiration dates were considered 
accurate if the expiration date in the EMR was the same as the expiration date associated 
with the lot number in the reference file. Records were excluded from expiration date 
analysis if lot number was not accurate because expiration date could not then be verified or 
if the reference file did not include expiration date for that vaccine lot.
Data Analysis
We performed chi-square analysis to compare the frequency of accurate lot numbers and 
expiration dates entered by 2D barcode scanning with the frequency of accurate data entered 
via traditional methods. To account for potential confounders, we created one multilevel 
logistic regression model for each of the dependent variables of interest—lot number 
accuracy and expiration date accuracy. The independent variable of interest was data entry 
method (2D barcode scan or traditional methods). We selected independent variables for 
inclusion in the final models through a backward elimination process that accounted for 
multicollinearity and model fit assessed by maximum likelihood estimation. We tested the 
following independent variables for inclusion: indicator that a vaccine was scanned, type of 
scan log (native versus installed scan log), state, facility specialty (pediatric versus all other), 
EMR type, manufacturer (A, B, C and all others combined), month the vaccine was 
administered (July 2014 through January 2015), facility type (privately-funded, publicly-
funded, or mass vaccinator as self-identified), type of barcode (2D versus linear), facility 
vaccination volume (high > 400 per week; low ≤ 400 per week), and vaccine type (influenza 
vaccine versus non-influenza). Final models included site-specific random intercepts; other 
potential confounding factors (manufacturer, scan log type, facility type, facility vaccine 
volume, month vaccine administered, vaccine type, facility specialty) were included as fixed 
effects. We calculated unadjusted and adjusted odds ratios to examine the impact of each 
variable on lot number and expiration date accuracy in the presence and absence of potential 
confounding factors. We attempted to include all independent variables in both models, but 
the inclusion of facility funding type and vaccine volume failed to find a solution in the 
expiration date model; therefore, these variables were only included in the final lot number 
model.
Given the large sample size, we determined 0.001 to be the appropriate alpha for 
determining statistical significance using a Bonferroni adjustment, which corresponds to a 
99% confidence interval.[19] Statistical models were run using SAS 9.2 (Carey, NC).
Results
Thirty-four facilities participated. Two facilities were unable to provide vaccination records 
at the end of the project; therefore, we analyzed records from 32 (94%) facilities. Among the 
facilities included in the analysis, 22 (69%) had native scan logs and ten (31%) had scan logs 
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installed. We collected 128,573 vaccination administration records from six different EMR 
types. We excluded 11,145 expiration date records (as described in the methods); 117,428 
records were available for expiration date analysis (Table 1). Facilities focused on pediatrics 
(n = 13) or other specialties (n = 19). Facilities were either privately-funded (n = 19), 
publicly-funded (n = 8) or mass vaccinators (n = 5). For both lot number and expiration date, 
the majority of all records scanned (77.7% lot number; 92.8% expiration date) and entered 
via traditional methods (96.9% lot number; 98.8% expiration date) came from privately-
funded vaccinators.
A higher percentage of lot numbers were accurate when entered via 2D barcode scanning 
(96.1%) compared with traditional methods (94.3%) (X2 = 84.4682, P < .001) (Figure 2). A 
higher percentage of expiration dates were accurate when entered via 2D barcode scanning 
(95.8%) compared with traditional methods (84.8%) (X2 = 1,113.55, P < .001).
When data were entered via 2D barcode scan, lot number was 1.48 (99% CI, 1.34–1.64) 
times more likely to be accurate and expiration date was 4.09 (99% CI, 3.68–4.55) times 
more likely to be accurate compared with traditional methods. When controlling for other 
potential confounders, lot number was 1.75 (99% CI, 1.57–1.96) (Table 2) times more likely 
to be accurate and expiration date was 2.39 (99% CI, 2.12–2.68) (Table 3) times more likely 
to be accurate when scanned compared with traditional methods of data entry.
The multilevel logistic regression models showed that factors other than 2D barcode 
scanning were associated with lot number and expiration date accuracy. Parameter estimates 
for vaccine manufacturer, month of vaccine administration, and vaccine type were associated 
with accuracy of both lot number and expiration date. Compared with Manufacturer B, 
records for vaccines from Manufacturer A (adjusted odds ratio [aOR] = 2.94; 99% CI, 2.57–
3.36) and other manufacturers (aOR = 2.34; 99% CI, 2.01–2.72) were more likely to have 
accurate lot numbers, whereas Manufacturer C (aOR = 0.48; 99% CI, 0.42–0.54) was less 
likely to have accurate lot numbers. For expiration date, data from Manufacturers C (aOR = 
0.41; 99% CI, 0.35–0.47) and other manufacturers (aOR = 0.04; 99% CI, 0.03–0.04) were 
less likely to be accurate than Manufacturer B. Lot number data were more likely to be 
accurate when recorded between September and December 2014 than in July 2014 (Table 2). 
However, compared with July 2014, expiration date was more likely to be accurate between 
October 2014 and January 2015 (Table 2) and less likely to be accurate in August (aOR = 
0.49; 99% CI, 0.44–0.54) and September 2014 (aOR = 0.53; 99% CI, 0.48–0.59). Data for 
both lot number (aOR = 4.07; 99% CI, 3.77–4.40) and expiration date (aOR = 2.38; 99% CI, 
2.21–2.55) were more likely to be accurate when an influenza vaccine was recorded 
compared to all other types of vaccines combined.
Discussion
This is the first published evaluation of the impact of 2D vaccine barcode use on data 
accuracy in the United States. Overall, lot number and expiration date in vaccine 
administration records were more accurate when data were entered via 2D barcode scanning 
compared with traditional methods, even after controlling for potential confounders. Lot 
number accuracy was 1.8 percentage points higher and expiration date accuracy was 11 
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percentage points higher when entered by 2D scanning compared with traditional methods. 
Two considerations should be made regarding the difference in lot number accuracy 
compared with the difference in expiration date accuracy. First, there may be more attention 
paid to recording lot number accurately when using traditional methods since it is required.
[1] Second, there is less room for positive change given the high lot number accuracy using 
traditional methods.
Manufacturer, month of vaccine administration, and vaccine type were associated with 
variation in accuracy of lot number and expiration date. Variation of accuracy by 
manufacturer may be due to factors such as curvature of the barcode on the vaccine vial, 
location of the barcode on the vial, vial size, or print quality of the barcodes or human-
readable labels.[15] We hypothesized that variation in accuracy by month could be due to 
increase in vaccination activity in September and October when children begin the school 
year.[20,21] However, in some busy vaccination months data quality were more accurate. 
This evaluation was conducted over seven months and associations between accuracy and 
month of vaccination might change if conducted over an entire year. Influenza vaccine data 
were more likely to be accurate compared with all other vaccines combined. There may be 
something unique about the influenza vaccine administration process that is driving this 
variation. Additionally, facility funding type and vaccine volume may be related to 
expiration date quality; however, since these variables were unable to be included in the 
model, no determination can be made about impact of these variables on expiration date 
accuracy. The reasons why these variables are associated with vaccination data accuracy 
have not been fully explored and additional research is suggested to better understand how to 
improve vaccine administration data.
Although not captured in our analyses, we observed other factors that affect data quality and 
may warrant further investigation. Manufacturer name is a data element required by the 
NCVIA and is derived from the product NDC, which is embedded in the Global Trade Item 
Number (GTIN).[1,22] To record the manufacturer name, EMRs have to interpret the 
vaccine’s GTIN and then interpret the NDC to capture manufacturer name. We had planned 
to examine the association between accuracy of manufacturer name and 2D barcode 
scanning; however, most EMR systems were unable to interpret the NDC. CDC maintains 
guidance on functional capabilities for EMR software solutions to capture and process 2D 
barcoded vaccine data.[23]
Given the improvement in data accuracy associated with 2D barcode scanning demonstrated 
in this evaluation, increased adoption of 2D barcode scanning technology by vaccine 
providers and enhancement of EMR systems to capture scanned 2D barcoded information is 
likely to improve vaccine administration data quality. EMR enhancements should include the 
ability to readily interpret NDCs and populate vaccine manufacturer, vaccine name, and 
dosage upon scanning. Vaccination providers can work with their EMR vendors to create 
alternatives for recording vaccine information that is currently being appended to lot 
number, vaccine name, and manufacturer, such as vaccine funding source. Further 
integration of EMR and 2D barcode scanning has the potential to improve quality control 
and reduce medical errors. For example, EMRs could be programed to alert users if the 2D 
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barcode scanned is for the wrong vaccine or dosage or if the vaccine has expired or been 
recalled.
The findings from this evaluation should be interpreted with several methodological 
limitations in mind. First, enrollment was voluntary, which may have resulted in selection 
bias; participating facilities may not be representative of all vaccinating facilities in the 
United States. For instance, volunteer facilities may have higher initial data quality or 
interest in data accuracy, and if so, we may be underestimating the potential contribution of 
2D barcode scanning. Second, although we controlled for a number of factors when 
examining the association of 2D barcode scanning with lot number and expiration date 
accuracy, other variables such as user characteristics, workflow practices, traditional method 
of data entry, and EMR type may play a role in data accuracy. Another limitation is the 
possibility of misclassification in the subset of data where the team matched EMRs with a 
separate text file to identify if a record was scanned or entered by traditional methods. 
Misclassification might occur if a scanned lot number failed to populate into an otherwise 
complete vaccination record. In this case, lot numbers in the scan log would not be matched 
to the EMR and records could not be identified as scanned. The reference file protocol was 
designed to ensure the data were comprehensive and from the most reliable source, but the 
file is limited by the data available (e.g., data were not always complete and not obtained 
directly from all vaccine manufacturers). If a lot number was accurately recorded but not 
included in the reference file, the record would be misclassified as inaccurate.
The improvement in data accuracy of scanned vaccine administration records observed in 
this evaluation has the ability to make a significant impact on vaccine safety given the 
number of records that could be affected by this change. Each year in the United States, 
approximately 10 million vaccines are administered to children younger than one year of 
age.[24] If the accuracy of all lot numbers recorded for this age group increased by 1.8%, 
this could equate to an additional 180,000 vaccine administration records with the correct lot 
number. For the same age group, an 11% increase in accurate expiration dates would mean 
1.1 million additional vaccination records would contain accurate expiration dates. The 
number of records with more accurate data could grow considerably when we consider the 
millions of additional vaccinations given to individuals over one year of age.
Conclusions
Our evaluation demonstrates that vaccine lot number and expiration date are more accurately 
captured via 2D barcode scanning than when entered via traditional methods. These findings 
suggest that increased availability and use of 2D barcodes on vaccines and widespread 
adoption of 2D barcode scanning will improve vaccination data accuracy. Improving 
interoperability between EMRs and 2D barcode scanners so that all data elements encoded 
in 2D barcodes can automatically populate would likely increase adoption of 2D barcode 
scanning technology. Future research should explore reasons for variations in differences in 
data quality by month of year, vaccine manufacturer, and vaccine type. A similar study 
should be conducted to examine the accuracy of recorded manufacturer when entered via 2D 
barcode scanning once EMRs can populate this required data field.
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EMR Electronic medical record
FDA U.S. Food and Drug Administration
IIS Immunization Information System
NDC National Drug Code/product identifier
VAERS Vaccine Adverse Event Reporting System
VFC Vaccines for Children
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Figure 1. Components of Linear Barcode and 2D Barcode on Vaccine Vials
Either GTIN or NDC is encoded in a linear barcode. NDC is a unique 10-digit, 3-segment 
number that identifies labeler, product, and trade package size. GTIN (Global Trade Item 
Number) is a global product identification standard in which the NDC is encoded.
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Figure 2. Accuracy of Lot Number and Expiration Date When Entered via Traditional Methods 
or 2D Barcode Scanning
Using chi-square tests the differences between the percentage of accurate data using 
traditional methods and 2D barcode scanning is statistically significant at the P < .001 level.
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Table 2




 2D Barcode Scanned 1.48 (1.34 – 1.64) 1.75 (1.57 – 1.96)
 Traditional Entry 1.00 [Reference] 1.00 [Reference]
Scan Log Typeb
 Installed Scan Log 1.06 (0.95 – 1.18) 1.14 (0.42 – 3.10)
 Native Scan Log 1.00 [Reference] 1.00 [Reference]
Manufacturer
 Manufacturer A 1.91 (1.69 – 2.15) 2.94 (2.57 – 3.36)
 Manufacturer B 1.00 [Reference] 1.00 [Reference]
 Manufacturer C 0.60 (0.54 – 0.66) 0.48 (0.42 – 0.54)
 Other Manufacturers 1.41 (1.23–1.62) 2.34 (2.01–2.72)
Month Administered
 July 2014 1.00 [Reference] 1.00 [Reference]
 August 2014 0.94 (0.83 – 1.06) 0.93 (0.82 – 1.06)
 September 2014 1.66 (1.47 – 1.88) 1.41 (1.24 – 1.61)
 October 2014 1.39 (1.25 – 1.56) 1.09 (0.96 – 1.23)
 November 2014 1.23 (1.10 – 1.39) 1.03 (0.91 – 1.17)
 December 2014 1.17 (1.04 – 1.32) 1.07 (0.95 – 1.22)
 January 2015 1.08 (0.96 – 1.21) 1.00 (0.88 – 1.13)
Facility Vaccine Volumec
 High 0.61 (0.57 – 0.65) 0.59 (0.29 – 1.18)
 Low 1.00 [Reference] 1.00 [Reference]
Facility Funding Type
 Publicly Funded 1.11 (0.94 – 1.30) 0.30 (0.05 – 1.66)
 Privately Funded 1.00 [Reference] 1.00 [Reference]
Facility Specialty
 Pediatrics Specialty 0.90 (0.84 – 0.96) 1.17 (0.53 – 2.62)
 All Other Specialties 1.00 [Reference] 1.00 [Reference]

















 Flu Vaccine 1.87 (1.75 – 2.01) 4.07 (3.77 – 4.40)
 Other Vaccine Types 1.00 [Reference] 1.00 [Reference]
a
OR is odds ratio.
b
Indicator for records that were scanned. Tracking software was installed or native to the EMR.
c
High volume >400 vaccines administered/week; low ≤400/week.
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Table 3




 2D Barcode Scanned 4.09 (3.68 – 4.55) 2.39 (2.12 – 2.68)
 Traditional Entry 1.00 [Reference] 1.00 [Reference]
Scan Log Typeb
 Installed Scan Log 1.74 (1.58 – 1.93) 1.80 (0.59 – 5.48)
 Native Scan Log 1.00 [Reference] 1.00 [Reference]
Manufacturer
 Manufacturer A 0.43 (0.38 – 0.50) 1.00 (0.86 – 1.16)
 Manufacturer B 1.00 [Reference] 1.00 [Reference]
 Manufacturer C 0.32 (0.28 – 0.37) 0.41 (0.35 – 0.47)
 Other Manufacturers 0.03 (0.03 – 0.03) 0.04 (0.03 – 0.04)
Month Administered
 July 2014 1.00 [Reference] 1.00 [Reference]
 August 2014 0.65 (0.60 – 0.71) 0.49 (0.44 – 0.54)
 September 2014 0.96 (0.88 – 1.03) 0.53 (0.48 – 0.59)
 October 2014 1.73 (1.60 – 1.88) 1.16 (1.05 – 1.28)
 November 2014 2.12 (1.94 – 2.32) 1.59 (1.43 – 1.78)
 December 2014 1.51 (1.39 – 1.65) 1.28 (1.15 – 1.42)
 January 2015 1.42 (1.31 – 1.55) 1.29 (1.16 – 1.43)
Facility Specialty
 Pediatrics Specialty 0.47 (0.44 – 0.49) 0.74 (0.27 – 2.03)
 All Other Specialties 1.00 [Reference] 1.00 [Reference]
Vaccine Type
 Flu Vaccine 3.30 (3.13 – 3.48) 2.38 (2.21 – 2.55)
 Other Vaccines 1.00 [Reference] 1.00 [Reference]
a
OR is odds ratio.
b
Indicator for records were scanned. Tracking software was installed or native to the EMR.
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